p53 directly represses Id2 to inhibit the proliferation of neural progenitor cells

Stem Cells

Volumn 29, Issue 7, 2011, Pages 1090-1101

  Paolella, Brenton R ^a   Havrda, Matthew C ^a   Mantani, Akio ^a   Wray, Christina M ^a   Zhang, Zhonghua ^a   Israel, Mark A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cell proliferation; Id2 genes; p53 genes; Stem cell

Indexed keywords

INHIBITOR OF DIFFERENTIATION 2; PROTEIN P53;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; GENE EXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; MOUSE; NERVE CELL INHIBITION; NEURAL STEM CELL; NONHUMAN; PROTEIN BLOOD LEVEL;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, P53; GLIOMA; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MICE; MICE, INBRED C57BL; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; PROMOTER REGIONS, GENETIC; STEM CELLS;

EID: 79960102625     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.660     Document Type: Article

References (54)

1. Lois C, Garcia-Verdugo JM, Alvarez-Buylla A. Chain migration of neuronal precursors. Science 1996;271:978-981. (Pubitemid 26066393)
2. Doetsch F, Caille I, Lim DA et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999;97:703-716. (Pubitemid 29278045)
3. Chen R, Nishimura MC, Bumbaca SM et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2011;17:362-375.
4. Pollard SM, Yoshikawa K, Clarke ID et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009;4:568-580.
5. Zheng H, Ying H, Yan H et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 2008;455:1129-1133.
6. Ferguson KL, Callaghan SM, O'Hare MJ et al. The Rb-CDK4/6 signaling pathway is critical in neural precursor cell cycle regulation. J Biol Chem 2000;275:33593-33600.
7. Alcantarallaguno S, Chen J, Kwon C et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009;15:45-56.
8. Gil-Perotin S. Loss of p53 induces changes in the behavior of subventricular zone cells: Implication for the genesis of glial tumors. J Neurosci 2006;26:1107-1116. (Pubitemid 43237042)
9. Meletis K. p53 suppresses the self-renewal of adult neural stem cells. Development 2005;133:363-369.
10. Dai C. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2001;15:1913-1925. (Pubitemid 32738621)
11. Wang Y, Yang J, Zheng H et al. Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell 2009;15:514-526.
12. Hesselager G, Uhrbom L, Westermark B et al. Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res 2003;63:4305-4309. (Pubitemid 36950994)
13. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-1068.
14. Li FP, Fraumeni JF, Jr, Mulvihill JJ et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988;48:5358-5362.
15. Havrda MC, Harris BT, Mantani A et al. Id2 is required for specification of dopaminergic neurons during adult olfactory neurogenesis. J Neurosci 2008;28:14074-14087.
16. Yun K. Id4 regulates neural progenitor proliferation and differentiation in vivo. Development 2004;131:5441-5448. (Pubitemid 39562186)
17. Jung S, Park R, Kim S et al. Id proteins facilitate self renewal and proliferation of neural stem cells. Stem Cells Dev 2009;19:831-841.
18. Benezra R, Davis RL, Lockshon D et al. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 1990;61:49-59.
19. Jogi A, Persson P, Grynfeld A et al. Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation. J Biol Chem 2002;277:9118-9126. (Pubitemid 34952988)
20. Cai L, Morrow EM, Cepko CL. Misexpression of basic helix-loop-helix genes in the murine cerebral cortex affects cell fate choices and neuronal survival. Development 2000;127:3021-3030.
21. Iavarone A, Garg P, Lasorella A et al. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev 1994;8:1270-1284.
22. Reynolds BA, Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996;175:1-13. (Pubitemid 26150042)
23. Groszer M, Erickson R, Scripture-Adams DD et al. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 2001;294:2186-2189. (Pubitemid 33150679)
24. Amundson SA, Do KT, Vinikoor LC et al. Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res 2008;68:415-424. (Pubitemid 351380067)
25. Jacks T, Remington L, Williams BO et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1-7.
26. Cicalese A, Bonizzi G, Pasi CE et al. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 2009;138:1083-1095.
27. Meek DW. Tumour suppression by p53: A role for the DNA damage response? Nat Rev Cancer 2009;9:714-723.
28. Gerdes J, Schwab U, Lemke H et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20. (Pubitemid 13179545)
29. Penuelas S, Anido J, Prieto-Sanchez RM et al. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 2009;15:315-327.
30. Sun P, Xia S, Lal B et al. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells 2009;27:1473-1486.
31. Wang B, Xiao Z, Ko HL et al. The p53 response element and transcriptional repression. Cell cycle 2010;9:870-879.
32. Mayor C, Brudno M, Schwartz JR et al. VISTA: Visualizing global DNA sequence alignments of arbitrary length. Bioinformatics 2000;16:1046-1047. (Pubitemid 32051021)
33. el-Deiry WS, Kern SE, Pietenpol JA et al. Definition of a consensus binding site for p53. Nat Genet 1992;1:45-49.
34. Hoffman WH, Biade S, Zilfou JT et al. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 2002;277:3247-3257. (Pubitemid 34953189)
35. Riley T, Sontag E, Chen P et al. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008;9:402-412.
36. Tokino T, Thiagalingam S, el-Deiry WS et al. p53 tagged sites from human genomic DNA. Hum Mol Genet 1994;3:1537-1542.
37. Bunz F. Requirement for p53 and p21 to Sustain G2 arrest after DNA damage. Science 1998;282:1497-1501. (Pubitemid 28538613)
38. Oliver FJ, de la Rubia G, Rolli V et al. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998;273:33533-33539. (Pubitemid 29005737)
39. Lee J, Kotliarova S, Kotliarov Y et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006;9:391-403. (Pubitemid 43668737)
40. Berglind H, Pawitan Y, Kato S et al. Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination. Cancer Biol Ther 2008;7:699-708.
41. Günther HS, Schmidt NO, Phillips HS et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008;27:2897-2909. (Pubitemid 351620450)
42. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401. (Pubitemid 39551674)
43. Israel MA, Hernandez MC, Florio M et al. Id gene expression as a key mediator of tumor cell biology. Cancer Res 1999;59:1726s-1730s.
44. Lasorella A, Iavarone A, Israel MA. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol Cell Biol 1996;16:2570-2578. (Pubitemid 26161260)
45. Wang B, Xiao Z, Ren EC. Redefining the p53 response element. Proc Natl Acad Sci USA 2009;106:14373-14378.
46. Riley T, Sontag E, Chen P et al. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008;9:402-412.
47. Balagurumoorthy P, Lindsay SM, Harrington RE. Atomic force microscopy reveals kinks in the p53 response element DNA. Biophys Chem 2002;101-102:611- 623. (Pubitemid 35462075)
48. Fontemaggi G, Dell'orso S, Muti P et al. Id2 gene is a transcriptional target of the protein complex mutant p53/E2F1. Cell Cycle 2010;9:2464-2466.
49. Yan W, Liu G, Scoumanne A et al. Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations. Cancer Res 2008;68:6789-6796.
50. Oren M, Rotter V. Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol 2010;2:a001107.
51. Verhaak RGW, Hoadley KA, Purdom E et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98-110.
52. Perk J, Iavarone A, Benezra R. Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 2005;5:603-614. (Pubitemid 41081386)
53. Chen Y, Wu H, Wang S et al. The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nature Neurosci 2009;12:1398-1406.
54. Samanta J. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 2004;131:4131-4142. (Pubitemid 39276185)